In patients with CIDP, subjective and objective improvement was noted but there could possibly be a placebo effect as well in terms of subjective well being particularly in patients with predominantly sensory symptoms, which is difficult to delineate from pharmacologic effects of the drug.People who were at baseline on pyridostigmine for MG remained on this drug and people who were at baseline on